<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01324921</url>
  </required_header>
  <id_info>
    <org_study_id>BK40</org_study_id>
    <nct_id>NCT01324921</nct_id>
  </id_info>
  <brief_title>Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics</brief_title>
  <official_title>Effect of Nutritional Products on Metabolic Parameters in Subjects With Type 2 Diabetics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Nutrition</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the postprandial glycemic and insulinemic response of subjects with type 2
      diabetes consuming a typical breakfast meal or no breakfast to 10004RF via a meal tolerance
      test (MTT).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">September 2010</completion_date>
  <primary_completion_date type="Actual">September 2010</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Positive AUC for plasma glucose concentration</measure>
    <time_frame>0 to 180 minutes</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma glucose concentrations</measure>
    <time_frame>0 to 180 minutes</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Positive AUC for serum insulin concentration</measure>
    <time_frame>0-180 minutes</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">37</enrollment>
  <condition>Diabetes Mellitus, Type 2</condition>
  <arm_group>
    <arm_group_label>No breakfast/beverage only</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>12 fluid ounces made up of one of some combination of the following: decaffeinated coffee, decaffeinated tea or water, with non-nutritive sweetener</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Breakfast</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 serving of unflavored instant oatmeal and 12 fluid ounces made up of one of some combination of the following: decaffeinated coffee, decaffeinated tea or water, with non-nutritive sweetener</description>
  </arm_group>
  <arm_group>
    <arm_group_label>10004RF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1 serving (8 fluid ounces) of the experimental beverage and 4 fluid ounces made up of one of some combination of the following: decaffeinated coffee, decaffeinated tea or water, with non-nutritive sweetener</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No breakfast/beverage only</intervention_name>
    <description>12 fluid ounces made up of one of some combination of the following: decaffeinated coffee, decaffeinated tea or water, with non-nutritive sweetener</description>
    <arm_group_label>No breakfast/beverage only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Breakfast</intervention_name>
    <description>1 serving of unflavored instant oatmeal and 12 fluid ounces made up of one of some combination of the following:decaffeinated coffee, decaffeinated tea or water, with non-nutritive sweetener</description>
    <arm_group_label>Breakfast</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>10004RF</intervention_name>
    <description>1 serving (8 fluid ounces) of the experimental beverage and 4 fluid ounces made up of one of some combination of the following:decaffeinated coffee, decaffeinated tea or water, with non-nutritive sweetener</description>
    <arm_group_label>10004RF</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. type 2 diabetes

          2. between 21 and 75 years of age

          3. male or a non-pregnant, non-lactating female, at least 6 weeks postpartum or
             postmenopausal or surgically sterile

          4. BMI is &gt; 18.5 kg/m2 and &lt;35 kg/m2

          5. If subject is on a chronic medication such as an anti-hypertensive, lipid-lowering,
             thyroid medication or hormone therapy, they have been on constant dosage for at least
             two months prior to screening visit.

        Exclusion Criteria:

          1. Hemoglobin A1c value at screening of greater than or equal to 9%.

          2. Uses exogenous insulin or exenatide for glucose control.

          3. type 1 diabetes.

          4. history of diabetic ketoacidosis.

          5. current infection; has had inpatient surgery, or corticosteroid treatment in the last
             3 months or antibiotics in the last 3 weeks prior to screening visit.

          6. active malignancy

          7. significant cardiovascular event â‰¤ six months prior to screening visit; or stated
             history of congestive heart failure.

          8. end-stage organ failure or is status post organ transplant.

          9. history of renal disease.

         10. current hepatic disease.

         11. history of severe gastroparesis.

         12. chronic, contagious, infectious disease

         13. taking any herbals, dietary supplements, or medications, other than anti-hyperglycemic
             medications, that could profoundly affect blood glucose.

         14. clotting or bleeding disorders

         15. allergic or intolerant to any ingredient found in the study products.

         16. habitual user of tobacco products (
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amy Devitt-Maicher, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Abbott Nutrition</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Provident Clinical Research and Consulting LLC</name>
      <address>
        <city>Glen Ellyn</city>
        <state>Illinois</state>
        <zip>60137</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radiant Research</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45249</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 27, 2011</study_first_submitted>
  <study_first_submitted_qc>March 28, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 29, 2011</study_first_posted>
  <last_update_submitted>March 29, 2011</last_update_submitted>
  <last_update_submitted_qc>March 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 30, 2011</last_update_posted>
  <responsible_party>
    <name_title>Bobbie Swearengin, Director Clinical Research Operations</name_title>
    <organization>Abbott Nutrition</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

